Company Data
Achilles Therapeutics plc
Ticker
ACHL
Current Price
$1.185 -0.42%
Market Cap
$48.7M
Price Target
Refer to Report
Volume
279.0K
52wk Range
$0.63 - $1.76
Overview
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.